Gynaecology Consultant Papers

tel: 01483 456836


  1. Whitcroft SIJ, Stevenson JC. HRT: risks and benefits. Clin.Endocrinol. 36:15-20,1992.
  2. Whitcroft SIJ, Stevenson JC. Osteoporosis. Current Opinions in Orthopaedics. 1992,3:77-81.
  3. Whitcroft SIJ, Whitehead MI. HRT and Breast Cancer. Br.J.Hosp.Med.48:7-9,1992.
  4. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Whitcroft SIJ, Ellerington ME, Lees B, Whitehead MI. Effect of transdermal or oral HRT on postmenopausal bone loss: a prospective controlled study. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990. pp 1999-2003.
  5. Stevenson JC, Lees B, Whitcroft SIJ, Ellerington ME, Hillard TC. Prevention of osteoporosis: pharmacologic intervention. In: Christiansen C, Overgaard K,eds. Osteoporosis 1990. Copenhagen: Osteopress ApS, 1990 pp 954-958.
  6. Whitcroft SIJ, Whitehead MI. The relative risk of breast cancer associated with HRT. Medical Dialogue. June 1990.
  7. Bruce R, Lees B, Whitcroft SIJ, McSweeney MB, Shaw RW, Stevenson JC. Changes in body composition with danazol therapy. Fertility and Sterility 1991,16:321-45.
  8. Hillard TC, Whitcroft SIJ, Ellerington ME, Whitehead MI. The long-term risks and benefits of H.R.T. Journal Clinical Pharmacy and Therapeutics. (1991) 16, 231-245.
  9. Stevenson JC, Hillard TC, Lees B, Whitcroft SI, Ellerington ME, Whitehead MI.Postmenopausal bone loss: does HRT always work? Int.J.Fert.Menopausal Studies.38,suppl.2:88-91,1993.
  10. Whitcroft SIJ, Whitehead MI. Choice of Progestogens in HRT. Modern Medicine.
  11. Stevenson JC and Whitcroft SIJ. Prevention and treatment of osteoporosis. In: Balint G, Gomor B, Hadinka L. (eds.) Rheumatology, State of the art. Amsterdam: Excerpta Medica, 1992 pp 282-283.
  12. Stevenson JC, Hillard TC, Whitcroft SI, Whitehead MI. Oestrogen replacement after oophorectomy (letter). Br.Med.J.305:712,1992.
  13. Contributions to MCQ's for the DRCOG- Hoghton M, Hogston P. Published by Churchill Livingstone. 1990
  14. Contributions to: HRT- Your Questions Answered. Whitehead MI. Godfree V. Published by Churchill Livingstone.
  15. Whitehead MI, Whitcroft SIJ, Hillard T.. An Atlas of the Menopause. Parthenon Publishing, Carnforth, U.K., 1993.
  16. Whitcroft SIJ, Ellerington ME, Whitehead MI. Routes of estrogen administration. In Asch RH, and Studd JWW. (eds). Annual Progress in Reproductive Medicine, 1993. pp.235-246. (Carnforth, U.K.: Parthenon Publishing).
  17. Ellerington ME, Whitcroft SIJ, Whitehead MI. Therapeutic and preventative aspects of estrogen and progesterone therapy. In Lorrain J, Plouffe Jr. L, Ravnikar V, Speroff L, Watts N. (eds). Comprehensive Management of Menopause. pp.269-285. (Springer Verlag, New York, 1994).
  18. Whitcroft SIJ. Monitoring hormone replacement therapy: Part 1. Well Woman Team 12:9-10, 1993.
  19. Ellerington ME, Whitcroft SIJ, Whitehead MI. HRT: developments in therapy. Br.Med.Bull. 48:401-25,1992.
  20. Whitcroft SIJ, Crook D, Marsh MS, Ellerington ME, Whitehead MI, Stevenson JC. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet.Gynecol.84:222-6,1994.
  21. Marsh MS, Whitcroft SIJ, Whitehead MI. Paradoxical effects of hormone replacement therapy on breast tenderness in postmenopausal women. Maturitas 19,97-102,1994.
  22. Marsh MS, Crook D, Lees B, Worthington M, Ellerington M, Whitcroft S, Whitehead MI, Stevenson JC. The effects of oral desogestrol and estradiol continuous combined hormone replacement therapy on serum lipids and body composition in postmenopausal women. Basic Life Sciences 60:219-220,1993.
  23. Stevenson JC, Whitcroft SIJ, Lees B, Godsland IF, Crook D. (1993) Effects of hormone deficiency on cardiovascular risk markers in women. Proc Br Cardiac Soc 113.
  24. Marsh MS, Crook D, Whitcroft SIJ, Worthington M, Whitehead MI, Stevenson JC. Effect of continuous combined estrogen and desogestrol hormone replacement therapy on serum lipids and lipoproteins. Obstet.Gynecol.83:19-23,1994.
  25. Hillard TC, Whitcroft SIJ, Marsh MS, Whitehead MI, Stevenson JC. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporosis Int. (1994) 4, 341-348.
  26. Herriot AM, Whitcroft SIJ, Y Jeanes. A retrospective audit of patients with polycystic ovary syndrome: the effects of a reduced glycaemic load diet. The Journal of Human Nutrition and Dietetics.21:337-345 (2008)
  27. Herriot AM, Whitcroft SIJ, Y Jeanes. A low Glycaemia index load diet reduces risk factors for the metabolic syndrome and type 2 diabetes in lean and overweight women with PCOS. The Journal of Human Nutrition and Dietetics.22:581-608 (2009)
  28. Herriot AM, Whitcroft SIJ, Insulin Resistance and Management of the menopause.